Induction of Transplant Tolerance in LDLT Via iTS

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 15, 2020

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Living-donor Liver Transplantation
Interventions
BIOLOGICAL

JB-101

induced T cell with suppressive function

Trial Locations (5)

Unknown

Juntendo University Hospital, Bunkyoku

Tokyo Women's Medical University Hospital, Shinjuku

Hiroshima University Hospital, Hiroshima

Kyoto University Hospital, Kyoto

Nagasaki University Hospital, Nagasaki

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Junten Bio Co., Ltd.

INDUSTRY

lead

Juntendo University

OTHER